LocVita® Vegan Vitamin D3

Back to Overview

Durlip™ Liposomal NAD+: Breaking Through Absorption Barriers

Jun 04,2026

Summary: As interest in healthy aging and cellular wellness continues to rise worldwide, Durlip™ Liposomal NAD+ is gaining attention as a next-generation solution designed to address one of the biggest challenges in NAD+ supplementation:
Summary:

多行文本内容元素

富文本内容绑定数据后可解析HTML语言内容

Durlip™ Liposomal NAD+: Breaking Through Absorption Barriers

As interest in healthy aging and cellular wellness continues to rise worldwide, Durlip™ Liposomal NAD+ is gaining attention as a next-generation solution designed to address one of the biggest challenges in NAD+ supplementation: poor absorption. Developed by INNOBIO, this advanced liposomal formulation improve the delivery and utilization of NAD+, helping consumers and brands achieve more benefits from this essential cellular coenzyme.

Why Traditional NAD+ Supplements Fall Short

NAD+ plays a critical role in cellular energy metabolism and numerous biological processes that support overall vitality. However, conventional oral NAD+ supplements often struggle to achieve meaningful absorption.

The challenge lies in the molecule itself. NAD+ has a relatively large structure, making it difficult to pass through cell membranes efficiently. As a result, a significant portion of traditional NAD+ may be degraded or remain inaccessible to cells after consumption. While precursors such as NMN and NR have become popular alternatives, their effectiveness still depends on multiple enzymatic conversion steps in the body, which can vary between tissues and individuals.

For supplement manufacturers, this absorption bottleneck has created a common industry challenge: higher doses do not always lead to better outcomes.

INNOBIO’s Advanced Liposomal Delivery Solution

To overcome these limitations, INNOBIO developed its proprietary Durlip™ Liposome Technology Platform. Through this technology, NAD+ is encapsulated within a phospholipid bilayer that helps protect the active ingredient during digestion while supporting more efficient transport and absorption.

Unlike conventional formulations, Durlip™ Liposomal NAD+ utilizes liposomal delivery to enhance ingredient stability and improve bioavailability. The liposome acts as a protective carrier, helping NAD+ reach its intended destination more effectively.

This approach reflects a growing trend in the nutraceutical industry, where delivery technology is becoming just as important as the active ingredient itself.

Robust Structural Characterization Supports Product Quality

INNOBIO has conducted extensive characterization studies to evaluate the physical properties of Durlip™ Liposomal NAD+.

Test results show a uniform liposomal structure with an average particle size of approximately 206 nm. Advanced microscopic analysis, including SEM and TEM imaging, demonstrates complete spherical liposome formation and successful encapsulation of NAD+ within the lipid carrier.

Further X-ray diffraction analysis revealed that the distinct crystalline structure present in unencapsulated NAD+ is significantly reduced after liposomal encapsulation, indicating that the active ingredient is effectively integrated into the delivery system.

These findings provide strong evidence that Durlip™ Liposomal NAD+ is not simply a blend of ingredients, but a carefully engineered formulation supported by advanced technology.

Enhanced Bioavailability Creates New Opportunities

The true value of any supplement ingredient depends on how efficiently it can be utilized by the body. According to bioavailability studies, Durlip™ Liposomal NAD+ demonstrated a significantly greater increase in plasma NAD+ levels compared with conventional NAD+ powder.

The results suggest that liposomal encapsulation can transform NAD+ from an ingredient with limited oral absorption into one that can be more effectively utilized after consumption.

For brands seeking meaningful product differentiation, this represents an important advantage. Rather than competing solely on higher potency claims, manufacturers can focus on delivering better utilization and better results for consumers.

INNOBIO: Driving the Future of Functional Nutrition

As the dietary supplement industry evolves, innovation is increasingly shifting from ingredient selection to delivery efficiency. INNOBIO believes that the next generation of functional nutrition products will be defined not only by what they contain, but by how effectively those ingredients are delivered and absorbed.

With its proprietary liposomal technology, rigorous characterization data, and demonstrated bioavailability advantages, Durlip™ Liposomal NAD+ offers a practical solution for brands looking to develop premium, science-backed wellness products.

By breaking through traditional absorption barriers, Durlip™ Liposomal NAD+ is helping redefine the future of effective NAD+ supplementation—starting with what matters most: absorption.

PREVIOUS:

Related Information

Durlip™ Liposomal Glutathione & NAD⁺: Breaking Through Absorption Barriers

In the dietary supplement industry, Glutathione (GSH) and NAD+ have long been recognized for their powerful benefits. GSH is well-documented for skin brightening and liver support, while NAD+ is widely regarded as a core coenzyme in cellular energy metabolism.

General Request

+86
  • +86 CN
SUBMIT

Take Appointment

+86
  • +86 CN
Submit